论文部分内容阅读
放射性药品系指用于临床诊断治疗的放射性核素制剂或者称其为标记药物。我国临床核医学使用放射性药品进行诊断和治疗始于五十年代后期。当时放射性药品的供应全部依赖于国外进口。六十年代初期,我国开始研制放射性药品,国家科委、卫生部在中国药品生物制品检定所设置了放射性药品质量检验机构,此后又在上海市药品检验所筹建了核医药室(同位素室)。1965年由中国药典委员会首次制定了二种放射性药品
Radiopharmaceuticals refer to a radionuclide formulation used as a clinical diagnostic treatment or a labeled drug. China’s clinical nuclear medicine using radioactive drugs for diagnosis and treatment began in the late fifties. The supply of radiopharmaceuticals at that time all relied on imports from abroad. In the early 1960s, China started the development of radiopharmaceuticals. The State Science and Technology Commission and the Ministry of Health set up a radioactive drug quality inspection agency in China’s pharmaceutical and biological products inspection office. Since then, a nuclear medicine room (isotope room) has been set up in the Shanghai Drug Inspection Station. In 1965 the Chinese Pharmacopoeia Commission for the first time developed two kinds of radioactive drugs